Trademark: 90560770
Status Date
Monday, July 31, 2023
Filing Date
Thursday, March 4, 2021
Published for Opposition
Tuesday, November 2, 2021
Abandoned Date
Monday, July 31, 2023
5 blood plasma derivatives and immunoglobulin preparations for therapeutic treatment against COVID-19
Jul 31, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 31, 2023
Abandonment - No Use Statement Filed
Dec 22, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 20, 2022
Sou Extension 2 Granted
Dec 20, 2022
Sou Extension 2 Filed
Dec 20, 2022
Teas Extension Received
Jun 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 27, 2022
Sou Extension 1 Granted
Jun 27, 2022
Sou Extension 1 Filed
Jun 27, 2022
Teas Extension Received
Dec 28, 2021
Noa E-Mailed - Sou Required From Applicant
Nov 2, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 2, 2021
Published For Opposition
Oct 13, 2021
Notification Of Notice Of Publication E-Mailed
Sep 27, 2021
Approved For Pub - Principal Register
Sep 27, 2021
Assigned To Examiner
Jun 3, 2021
New Application Office Supplied Data Entered
Mar 8, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24